Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Prostate Cancer

Erleada First Drug Approved for Patients with Nonmetastatic Prostate Cancer
On February 14, 2018, the FDA approved Erleada (apalutamide; from Janssen) for the treatment of patients with nonmetastatic, castration-resistant prostate cancer. Read More ›

Zytiga Approved for New Type of Metastatic Prostate Cancer

Run Your Race: What It  Means to Be a Care Partner
Here is some valuable advice regarding being a care partner. Kristin Ainsworth learns that taking care of her husband, who was diagnosed with prostate cancer, also requires her taking care of herself. Read More ›

PSA Screening Saved His Life, Said Ben Stiller After Being Diagnosed with Prostate Cancer
You know Ben Stiller as the comedic actor who made you laugh in “There’s Something About Mary,” “Zoolander,” and “Meet the Parents,” but this legend of the silver screen credits a PSA screening for saving his life. Read More ›

Surviving, and Thriving, in the Face of Prostate Cancer
Faced with a late-in-life diagnosis of prostate cancer, Bill Sneddon describes his positive experience with Proton therapy, the emerging alternative treatment to standard x-ray radiation. Read More ›

My Passion for Model Building Keeps Me Going While Dealing with Cancer

My Dad’s Prostate Cancer
The decision to watch and wait was right for my dad and for our family, and being able to talk about all the options with the doctor and primary nurse helped us make the right decision. Read More ›

Dealing with a Prostate Cancer Diagnosis
Cancer is a family affair, whether we like it or not. When one is faced with a cancer diagnosis, family members (and friends) are also affected. Read More ›

Page 3 of 3